1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAM173A CTRPv2 pan-cancer AAC 0.09 0.01
mRNA BMP8B CTRPv2 pan-cancer AAC 0.088 0.01
mRNA KBTBD8 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA GPRASP2 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA SPATS2L CTRPv2 pan-cancer AAC 0.1 0.01
mRNA ZC3H12B CTRPv2 pan-cancer AAC -0.094 0.01
mRNA B3GNT7 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA CYB5R3 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA IL33 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA FAM72D CTRPv2 pan-cancer AAC -0.11 0.01
Download CSV